Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis.

IF 4.8 4区医学

Human Vaccines & Immunotherapeutics Pub Date : 2024-09-18 DOI:10.1080/21645515.2024.2403170

Qianyu Wang,Gang Pan,Yu Zhang,Yiqin Ni,Yuzhu Mu,Dingcun Luo

{"title":"Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis.","authors":"Qianyu Wang,Gang Pan,Yu Zhang,Yiqin Ni,Yuzhu Mu,Dingcun Luo","doi":"10.1080/21645515.2024.2403170","DOIUrl":null,"url":null,"abstract":"Thyroid cancer is a common endocrine malignancy that poses considerable therapeutic challenges in treating anaplastic carcinoma and advanced aggressive disease. Immunotherapy has become a prominent strategy for cancer treatment, and has shown remarkable advancements in recent years. In this study, we utilized visualization and bibliometric tools to analyze publications on thyroid cancer immunotherapy from the Web of Science Core Collection (WoSCC). A total of 409 articles were included, with an annual increase in both publications and citations since 2016. China leads research efforts in this area, while the University of Texas System and UTMD Anderson Cancer Center rank first in publication output. The journal Thyroid has garnered the highest citations. Notable authors contributing to this field include Antonelli Alessandro, Fallahi Poupak, and Wang Yu. Current research hotspots include immune checkpoint inhibitors, combination therapies involving immunotherapy with targeted therapy, CAR-T cell therapy, and modulation of the tumor microenvironment, all of which underscore the evolving landscape and potential for innovative treatments in thyroid cancer.","PeriodicalId":13058,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"119 1","pages":"2403170"},"PeriodicalIF":4.8000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Vaccines & Immunotherapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21645515.2024.2403170","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Thyroid cancer is a common endocrine malignancy that poses considerable therapeutic challenges in treating anaplastic carcinoma and advanced aggressive disease. Immunotherapy has become a prominent strategy for cancer treatment, and has shown remarkable advancements in recent years. In this study, we utilized visualization and bibliometric tools to analyze publications on thyroid cancer immunotherapy from the Web of Science Core Collection (WoSCC). A total of 409 articles were included, with an annual increase in both publications and citations since 2016. China leads research efforts in this area, while the University of Texas System and UTMD Anderson Cancer Center rank first in publication output. The journal Thyroid has garnered the highest citations. Notable authors contributing to this field include Antonelli Alessandro, Fallahi Poupak, and Wang Yu. Current research hotspots include immune checkpoint inhibitors, combination therapies involving immunotherapy with targeted therapy, CAR-T cell therapy, and modulation of the tumor microenvironment, all of which underscore the evolving landscape and potential for innovative treatments in thyroid cancer.

查看原文本刊更多论文

从免疫疗法角度看甲状腺癌的新进展：文献计量分析。

甲状腺癌是一种常见的内分泌恶性肿瘤，在治疗无细胞癌和晚期侵袭性疾病方面面临着巨大的治疗挑战。免疫疗法已成为癌症治疗的重要策略，近年来取得了显著进展。在本研究中，我们利用可视化和文献计量学工具分析了科学网核心数据库（WoSCC）中有关甲状腺癌免疫疗法的文献。共收录了409篇文章，自2016年以来，发表量和引用量均呈逐年上升趋势。中国在这一领域的研究工作处于领先地位，而德克萨斯大学系统和UTMD安德森癌症中心在论文产出方面排名第一。甲状腺》杂志的引用率最高。在这一领域做出贡献的著名作者包括安东内利-亚历山德罗、法拉希-普帕克和王宇。目前的研究热点包括免疫检查点抑制剂、免疫疗法与靶向疗法的联合疗法、CAR-T细胞疗法以及肿瘤微环境调控，所有这些都凸显了甲状腺癌创新疗法不断发展的前景和潜力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

自引率

8.30%

发文量

审稿时长

1 months

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.